ZTE MRI Pulse Sequence Use for Visualization of Bone Cement, Breast Biopsy Markers
NCT06873802 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2025-09-09
Summary
This study is being done to determine if a clinically available MRI sequence called ZTE imaging better visualizes breast biopsy markers made of bone cement compared to the currently used breast biopsy markers made of metal.
Conditions
- Breast Carcinoma
Interventions
- OTHER
-
Non-Interventional Study
Non-interventional study
Sponsors & Collaborators
-
National Institute for Biomedical Imaging and Bioengineering (NIBIB)
collaborator NIH - lead OTHER
Principal Investigators
-
Christine U. Lee, MD, PhD · Mayo Clinic in Rochester
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-04-11
- Primary Completion
- 2025-07-25
- Completion
- 2025-07-25
Countries
- United States
Study Locations
More Related Trials
-
Pre-biopsy With Dynamic Acquisitions
NCT00943644 ·Status: COMPLETED
-
Pilot Study to Validate Metallic Markers for Image Guided Radiation Therapy for Breast Cancer Tx
NCT00802932 ·Status: COMPLETED
-
A Study Comparing ex Vivo MRI Versus Radiography of Breast Specimens
NCT01869335 ·Status: UNKNOWN ·Phase: NA
-
Contrast-enhanced MR Imaging as a Breast Cancer Screening in Women at Intermediate Risk
NCT02210546 ·Status: UNKNOWN ·Phase: NA
-
Comparison of MRI and Molecular Breast Imaging in Breast Diagnostic Evaluation
NCT00591864 ·Status: COMPLETED ·Phase: NA
-
Magnetic Resonance Imaging in Patients With Breast Cancer
NCT00610181 ·Status: COMPLETED
-
Extent of Breast Cancer and the Role of Pre-Operative Sonography and MRI
NCT02587663 ·Status: COMPLETED ·Phase: NA
-
Magnetic Resonance Imaging of Breast Cancer
NCT01035112 ·Status: RECRUITING ·Phase: NA
-
Study of 68Ga /131I SGMIB-ZT-199 PET Imaging Targeting HER2-positive in the Diagnosis of Metastatic Breast Cancer
NCT05982626 ·Status: RECRUITING ·Phase: NA
-
Benefit of a Diagnostic MRI in Case of Pathological Nipple Discharge With Normal Mammography / Ultrasound
NCT02819362 ·Status: COMPLETED
-
Improving Characterization of Calcifications With Contrast-Enhanced Mammography
NCT03639129 ·Status: WITHDRAWN ·Phase: NA
-
Breast MRI in Evaluation of Pathologic Response in Patients With Breast Cancer With Neoadjuvent Chemotherapy
NCT05301790 ·Status: UNKNOWN
-
An Imaging Technology, Contrast-Enhanced Mammography, in Predicting Breast Cancer
NCT04871139 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Evaluation of Half-Dose Molecular Breast Imaging With Wide Beam Reconstruction Processing
NCT01653964 ·Status: COMPLETED ·Phase: NA
-
Prospective Comparison of Breast MRI vs Contrast Mammography Prior to Surgery in Breast Cancer Patients
NCT04770714 ·Status: WITHDRAWN ·Phase: NA
-
Comparison of Positron Emission Mammography and Contrast-enhanced Breast MRI
NCT02770586 ·Status: COMPLETED ·Phase: NA
-
Contrast-Enhanced Mammography for the Evaluation of Mammographic Microcalcifications
NCT05046301 ·Status: ACTIVE_NOT_RECRUITING
-
Vibro-Acoustography Imaging in Diagnosing Breast Masses in Women With a Breast Mass or Breast Cancer
NCT00627614 ·Status: COMPLETED ·Phase: NA
-
Use of Low-dose Molecular Breast Imaging for the Detection of Small Breast Lesions
NCT01285440 ·Status: COMPLETED
-
Magnetic Resonance Imaging (MRI) Correlation to Standard of Care Imaging and Pathology Correlation in Breast Carcinoma
NCT00291304 ·Status: TERMINATED ·Phase: PHASE2
-
Evaluate the Use of the Magnetic Resonance Spectroscopy in Determining if the Breast Tumor is Benign or Malignant
NCT00639171 ·Status: COMPLETED
-
Magnetic Resonance Imaging in Women Receiving Chemotherapy for Stage III Breast Cancer
NCT00043017 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Three Methods for Early Detection of Breast Cancer
NCT03954015 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Breast MRI for Newly Diagnosed Breast Cancer:Impact on Re-excision Lumpectomy
NCT01568346 ·Status: TERMINATED ·Phase: PHASE3
-
Breast-Specific Gamma Imaging and Locally Advanced Breast Cancer Undergoing Neoadjuvant Chemotherapy
NCT02556684 ·Status: UNKNOWN